Home  >  Products  >  TBXAS1 (thromboxane A synthase 1 (platelet) ) Blocking Peptide (the C terminal of TBXAS1)(100ug)
TBXAS1 (thromboxane A synthase 1 (platelet) ) Blocking Peptide (the C terminal of TBXAS1)(100ug)

TBXAS1 (thromboxane A synthase 1 (platelet) ) Blocking Peptide (the C terminal of TBXAS1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TBXAS1 Antibody (ARP65284_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65284
Size: 100ug
Weight: 52kDa
Gene: 6916
Format: Lyophilized powder
Target: This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alternative names: CYP5; CYP5A1; FLJ52771; GHOSAL; THAS; TS; TXAS; TXS
See Full Product Listings >